ImmunoGen, Inc. (IMGN): Price and Financial Metrics
ImmunoGen, Inc. (IMGN)
Today's Latest Price: $5.59 USD
Updated Oct 29 1:20pm
Add IMGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
IMGN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for IMGN is -3.53 -- better than merely 3.18% of US stocks.
- IMGN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 2.96% of US stocks.
- Revenue growth over the past 12 months for ImmunoGen Inc comes in at 78.37%, a number that bests 93.3% of the US stocks we're tracking.
- Stocks that are quantitatively similar to IMGN, based on their financial statements, market capitalization, and price volatility, are MVIS, WVE, LPTX, BLCM, and RCUS.
- Visit IMGN's SEC page to see the company's official filings. To visit the company's web site, go to www.immunogen.com.
IMGN Stock Price Chart Interactive Chart >
IMGN Price/Volume Stats
| Current price | $5.59 | 52-week high | $7.07 |
| Prev. close | $5.41 | 52-week low | $1.95 |
| Day low | $5.32 | Volume | 712,386 |
| Day high | $5.63 | Avg. volume | 2,822,294 |
| 50-day MA | $4.28 | Dividend yield | N/A |
| 200-day MA | $4.27 | Market Cap | 975.69M |
ImmunoGen, Inc. (IMGN) Company Bio
Immunogen develops targeted anticancer therapeutics. The Company's ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. The company was founded in 1981 and is based in Waltham, Massachusetts.
Loading social stream, please wait...